Systematic review / meta-analysis / 2017
Ginkgo biloba extract at doses over 200 mg/day for at least 22 weeks showed potentially beneficial effects in dementia.
An overview was conducted of 12 systematic reviews with meta-analyses of randomized controlled trials evaluating Ginkgo biloba extract (GbE) for dementia or cognitive impairment. Available evidence suggested potentially beneficial effects over placebo on cognitive performance, activities of daily living, and clinical global impression at doses greater than 200 mg/day (usually 240 mg/day) given for 22 weeks or longer, while appearing safe. Doses under 200 mg/day or durations under 22 weeks lacked sufficient evidence for clinically relevant effects. However, the quality of evidence in the included reviews ranged from low to moderate.
- Study type
- Overview of systematic reviews and meta-analyses
- Who was studied
- People with dementia or cognitive impairment (from 12 systematic reviews)
- What was measured
- Cognitive performance, activities of daily living, and clinical global impression
THE PAPER
Effects of Ginkgo biloba on dementia: An overview of systematic reviews.
Yuan Q, Wang CW, Shi J, Lin ZX. J Ethnopharmacol, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.